Top Endoscopy Equipment and Software Companies

Global Endoscopy Equipment and Software Market size was valued at USD 49.02 Billion in 2024 and is poised to grow from USD 52.7 Billion in 2025 to USD 93.98 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026–2033).

Global endoscopy equipment and software market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Olympus Corporation (Japan) ', 'Boston Scientific Corporation (United States) ', 'Medtronic plc (Ireland) ', 'Johnson & Johnson (Ethicon Inc.) (United States) ', 'KARL STORZ SE & Co. KG (Germany) ', 'Fujifilm Holdings Corporation (Japan) ', 'Stryker Corporation (United States) ', 'HOYA Corporation (PENTAX Medical) (Japan) ', 'Smith & Nephew plc (United Kingdom) ', 'Cook Medical Inc. (United States) ', 'Ambu A/S (Denmark) ', 'Richard Wolf GmbH (Germany) ', 'STERIS plc (United States) ', 'Mauna Kea Technologies (France) ', 'EndoChoice Holdings Inc. (United States) ', 'NeoScope Inc. (United States) ', 'Machida Endoscope Co. Ltd. (Japan) ', 'Aohua Medical Technology Co. Ltd. (China) ', 'Interscope Inc. (United States)'

Endoscopic surgery is more advantageous due to the benefits like reduced pain, quicker recovery times, short or no hospital stays, less postoperative issues, and less complications during surgery, which will boost the market in the upcoming years. The demand for endoscopy is also increasing as more insurance companies in major and developing nations like the US, UK, India, Australia, Germany, Canada, and others are recognising the benefits of endoscopic surgery. This will ultimately help the market grow in the future. The demand for endoscopy equipment and software will rise in the forecast period due to the growing use of endoscopy to detect diseases like cancer, orthopaedic diseases, neurological diseases, gastrointestinal problems, and gastroesophageal reflux disorder (GERD) as well as target diseases, including cancer, neurodegenerative, infectious, immune, metabolic, and cardiovascular diseases.

The market is driven by the growing inclination of medical professionals for using technologically enhanced endoscopic devices outfitted with a high-definition camera and light sources to assist doctors in analysing interior organs of interest. The primary drivers projected to drive the demand for endoscopic equipment are the shift in preference toward minimally invasive surgical techniques over standard surgeries to shorten hospital stay and minimise post-procedure problems. Therefore, it is anticipated that factors including greater patient satisfaction, enhanced economic viability, and shorter hospital stays would increase the demand for minimally invasive endoscopic procedures in the years to come, fueling the market's expansion.

North America held the largest share in the market for endoscopy devices in 2021, owing to reimbursement policies for endoscopic treatments in the US insurance market, an increase in the number of cancer patients, high investments by hospitals to purchase new endoscopic equipment, a strong focus on research to improve endoscopy techniques, and the implementation of a new funding model by Canadian hospitals.